Sal-B down-regulated the expression of PKM2, LDHA, and GLUT1, affecting glucose uptake, lactate production, enolase activity, cellular ATP levels, and regulating cellular metabolic reprogramming in NSCLC (Chen B. et al., 2022). This evidence concerns the gene PKM and non-small cell lung carcinoma.